News
OncoCyte Corp (NASDAQ:OCX) launched Graft Assure, a kidney transplant test, with leading transplant centers, enhancing their IVD product development. The company achieved a breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback